Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSK with HER2 Vaccine in Stage IV Breast Cancer
NCT01922921Phase 2Completed
- Sponsor
- University of Washington
- Start
- Feb 2014
- Primary completion
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Microbiome-Derived Products
- Countries
- 1
01
Overview
A Phase 2 trial of polysaccharide k in breast cancer, sponsored by University of Washington. Started Feb 2014; status: completed.
02
Drugs
polysaccharide k
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01922921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922921.